Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b75779a7f3607c51b7d749acfaa9184 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-4631 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30672 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-3069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30677 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S623-901 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-003553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00353 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-30942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-38 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C39-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-38 |
filingDate |
2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9dc71c07aa445343a0d7f938f74a397 |
publicationDate |
2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8858207-B2 |
titleOfInvention |
Total knee joint mold and methods |
abstract |
In one embodiment, a method for treating an infected implant area of a knee joint comprises surgically accessing the implant area, and inserting a tibial component into the tibia using an antibiotic-impregnated material. A femoral component is formed that is configured to interact with the tibial component by stable knee joint articulation and motion. The femoral component is formed of an antibiotic-impregnated material using a mold. The femoral component is attached to the femur using an antibiotic-impregnated material, and the tibial component is interfaced with the femoral component to form a stable temporary knee joint capable of reducing the spread of infection while permitting movement of the knee joint. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344419-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021068963-A1 |
priorityDate |
2003-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |